Skip to main content

Clarus Therapeutics Holdings, Inc. (CRXT)

NASDAQ: CRXT · IEX Real-Time Price · USD
8.81 0.98 (12.52%)
Sep 17, 2021 4:00 PM EDT - Market closed
Market Cap69.77M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out5.81M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume-
Open-
Previous Close7.83
Day's Range7.95 - 9.60
52-Week Range0.00 - 9.60
Betan/a
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About CRXT

Blue Water Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Greenwich, Connecticut.

IndustryShell Companies
Founded2003
Stock ExchangeNASDAQ
Ticker SymbolCRXT
Full Company Profile

Financial Performance

Financial Statements

News

Clarus Therapeutics, McGill University Ink Licensing Pact For Rare CoQ10-Associated Conditions

Clarus Therapeutics Holdings Inc (NASDAQ: CRXT) and Canada's McGill University have announced licensing agreement whereby Clarus will develop and commercialize McGill's proprietary technology designed t...

Other symbols:CLAR
2 days ago - Benzinga

Clarus Therapeutics and McGill University Announce Exclusive Worldwide Licensing Agreement To Develop and Commerciali...

Agreement to accelerate development of potential treatments for rare, endocrine, metabolic, and neurological conditions associated with primary and secondary ubiquinone deficiencies which belong to the ...

2 days ago - GlobeNewsWire

Clarus Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

NORTHBROOK, Ill., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Nasdaq:CRXT), a specialty pharmaceutical company dedicated to providing solutions to unmet medical needs by advan...

3 days ago - GlobeNewsWire

Clarus Therapeutics Closes Transaction With Blue Water, Debuts as a Publicly Traded Company to Develop Androgen and M...

Business combination with Blue Water Acquisition Corp., a special purpose acquisition company, completed on September 9, 2021

1 week ago - GlobeNewsWire

Blue Water Acquisition Corp. Announces Stockholder Approval of Business Combination with Clarus Therapeutics, Inc.

GREENWICH, Conn., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (Nasdaq: BLUW), a special purpose acquisition company (“Blue Water”), today announced that its stockholders have voted to...

3 weeks ago - GlobeNewsWire

BLUW Stock: 11 Things to Know About Blue Water SPAC Amid Short-Squeeze Rumors

Blue Water Acquisition (BLUW) stock is heading higher on Thursday ahead of the SPAC's upcoming shareholder meeting and recent rumors. The post BLUW Stock: 11 Things to Know About Blue Water SPAC Amid Sh...

3 weeks ago - InvestorPlace

Blue Water Acquisition Corp. Announces Change of Special Meeting of Shareholders Date to August 27, 2021

NEW YORK, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (NASDAQ: BLUW) (“Blue Water” or the "Company"), a special purpose acquisition company (SPAC) that previously announced a planned ...

1 month ago - GlobeNewsWire

Blue Water Acquisition Corp. Announces Date for Special Meeting of Stockholders to Vote on Transaction With Clarus Th...

GREENWICH, Conn., July 30, 2021 /PRNewswire/ --  Blue Water Acquisition Corp. (Nasdaq: BLUW) ("Blue Water"), a special purpose acquisition company ("SPAC") led by Joseph Hernandez, today announced that ...

1 month ago - PRNewsWire

Clarus Therapeutics And HavaH Therapeutics Announce Licensing Agreement For Product To Treat Androgen-Dependent Infla...

NORTHBROOK, Ill. and NORTH ADELAIDE, South Australia, May 25, 2021 /PRNewswire/ -- Clarus Therapeutics Inc. ("Clarus"), a pharmaceutical company dedicated to providing solutions to unmet medical needs b...

3 months ago - PRNewsWire

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Blue Water Acquisition Corp. - BLUW

NEW YORK, May 4, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action S...

4 months ago - PRNewsWire

Blue Water Acquisition Corp. Receives Expected Notice from Nasdaq Regarding Delayed Annual Report

New York, NY, April 22, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (NASDAQ: BLUWU) (the “Company”) announced today that it received a notice (“Notice”) from the Listing Qualifications Departm...

4 months ago - GlobeNewsWire

Blue Water Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing Febr...

Greenwich, Conn., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (the “Company”) announced that, commencing February 9, 2021, holders of the units sold in the Company's initial public of...

7 months ago - GlobeNewsWire

Blue Water Acquisition Corporation Announces Closing of $57.5 Million Initial Public Offering, Including Full Exercis...

GREENWICH, Conn., Dec. 17, 2020 /PRNewswire/ -- Blue Water Acquisition Corporation (NASDAQ: BLUWU) (the "Company"), a special purpose acquisition company, announced today that it closed its initial publ...

9 months ago - PRNewsWire